Four cases of investigational therapy with interleukin-11 against acute myocardial infarction

Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies)

(2015) Antonio Abbate et al.   AMERICAN JOURNAL OF CARDIOLOGY

Impact of aging on the clinical outcomes of Japanese patients with coronary artery disease after percutaneous coronary intervention

(2013) Hidehiro Kaneko et al.   HEART AND VESSELS

Long-term incidence and prognostic factors of the progression of new coronary lesions in Japanese coronary artery disease patients after percutaneous coronary intervention

(2013) Hidehiro Kaneko et al.   HEART AND VESSELS

Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart

(2012) Masanori Obana et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Glycoprotein 130 Cytokine Signal as a Therapeutic Target Against Cardiovascular Diseases

(2011) Yasushi Fujio et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Therapeutic Activation of Signal Transducer and Activator of Transcription 3 by Interleukin-11 Ameliorates Cardiac Fibrosis After Myocardial Infarction

(2010) Masanori Obana et al.   CIRCULATION

Cardioprotection by Ischemic Postconditioning Is Lost in Aged and STAT3-Deficient Mice

(2007) Kerstin Boengler et al.   CIRCULATION RESEARCH